行情

NDRA

NDRA

ENDRA Life
NASDAQ

实时行情|Nasdaq Last Sale

0.9300
+0.0253
+2.80%
休市 16:00 12/06 EST
开盘
0.9300
昨收
0.9047
最高
0.9500
最低
0.9100
成交量
3.60万
成交额
--
52周最高
3.486
52周最低
0.6211
市值
699.07万
市盈率(TTM)
-0.6106
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NDRA 新闻

  • 意大利再次修正2020财政预算案 推多项惠民政策
  • 中国新闻网.4天前
  • 兴业银行:美国国债收益率或将因衰退风险而跌至1.2%
  • 新浪财经综合.4天前
  • 波音737 MAX审查进展:FAA局长将赴众院说明情况
  • 中国新闻网.4天前
  • 美股超级牛派:最近的下跌是早来的圣诞礼物
  • 新浪财经.4天前

更多

所属板块

生物技术和医学研究
+0.66%
制药与医学研究
+0.49%

热门股票

名称
价格
涨跌幅

NDRA 简况

ENDRA Life Sciences Inc. is engaged in commercialization of an enhanced ultrasound technology for the pre-clinical research market. The Company's Nexus 128 system combines light-based thermoacoustics and ultrasound, to address the imaging needs of researchers studying disease models in pre-clinical applications. The Company is involved in developing Thermo Acoustic Enhanced Ultrasound (TAEUS) for incorporation into new ultrasound systems. The TAEUS platform has capabilities and potential clinical applications, such as enabling ultrasound to distinguish fat from lean tissue; enabling traditional ultrasound to visualize changes in tissue temperature, in real time; enabling ultrasound to view blood vessels from any angle, using only a saline solution contrasting agent, unlike Doppler ultrasound which requires precise viewing angles, and enabling ultrasound to image blood flow at the capillary level in a region, organ or tissue.
展开

Webull提供ENDRA Life Sciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。